V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280006342 | 280003889 | 1.8 | 90 | Palliative (P) | 2018-01-14 | 2018-01-14 | OCTREOTIDE | Y | N | 280030718 | CISPLATIN + FLUOROURACIL + RT |
| 280006343 | 280003889 | 1.65 | 48.3 | Curative (C) | null | 2016-01-23 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 280030718 | BCG |
| 280006344 | 280003890 | null | 79.35 | Curative (C) | 2012-11-03 | 2012-11-15 | BENDAMUSTINE + RITUXIMAB | null | N | 280030722 | CISPLATIN + FLUOROURACIL + RT |
| 280006345 | 280003891 | 1.58 | null | Neo-adjuvant (N) | 2017-05-18 | 2017-05-25 | IVADo | null | null | 280030723 | RMS 2005 TRIAL |
| 280006346 | 280008125 | null | 71.8 | null | 2013-11-09 | 2013-11-18 | Vinorelbine IV | N | Y | 280030724 | LIPOSOMAL DOXORUBICIN |
| 280006347 | 280003892 | null | 75.9 | Palliative (P) | 2017-06-06 | 2017-06-07 | Y-90 | 02 | N | 280030725 | IPILIMUMAB |
| 280006348 | 280008126 | 1.58 | 7.8 | Curative (C) | 2017-01-05 | 2018-01-24 | LANREOTIDE | N | Y | 280030727 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE |
| 280006349 | 280008126 | 1.76 | 56.8 | Palliative (P) | null | 2016-09-23 | TCF | N | N | 280030727 | PACLITAXEL |
| 280006350 | 280008126 | 1.57 | 46 | Palliative (P) | 2015-06-01 | 2015-06-11 | CTD Attenuated (Thalidomide 50mg) | 02 | N | 280030727 | CARBOPLATIN + PEMETREXED |
| 280006351 | 280003893 | 1.75 | 86.4 | Palliative (P) | 2015-11-13 | 2015-12-15 | ECarboX | 2 | null | 280030731 | DOCETAXEL + GEMCITABINE |
| 280006352 | 280003894 | 1.7 | null | Curative (C) | 2015-03-04 | 2015-04-03 | GEMCITABINE | N | null | 280030732 | CISPLATIN + FLUOROURACIL + RT |
| 280006353 | 280003895 | 1.56 | 66.7 | Palliative (P) | 2016-11-19 | 2016-12-11 | EC | N | N | 280030733 | GEMCARBO |
| 280006354 | 280003896 | 1.47 | 77.7 | Palliative (P) | 2014-07-15 | 2014-07-16 | IMATINIB | N | N | 280030735 | CAPECITABINE |
| 280006355 | 280003897 | 1.66 | 48.6 | Palliative (P) | null | 2018-11-03 | Paclitaxel 7 day | N | N | 280030737 | TRABECTEDIN |
| 280006356 | 280003898 | 1.7 | 91 | Palliative (P) | 2015-01-18 | 2015-01-24 | IVADo | N | N | 280030738 | DOCETAXEL |
| 280006357 | 280003899 | 1.65 | 71.2 | Palliative (P) | 2015-01-31 | 2015-02-05 | VAC | 02 | N | 280030739 | DOCETAXEL + GEMCITABINE |
| 280006358 | 280003899 | 1.78 | 38.8 | Neo-adjuvant (N) | 2017-07-04 | 2017-07-06 | VAC | N | N | 280030739 | CARBO + FLUOROURACIL |
| 280006359 | 280003899 | null | 101.5 | Curative (C) | null | 2013-10-29 | ETOPOSIDE | null | null | 280030739 | RMS 2005 TRIAL |
| 280006360 | 280003900 | 1.82 | 52.1 | null | 2013-04-09 | 2013-04-09 | MELPHALAN | N | N | 280030744 | VIDE |
| 280006361 | 280003900 | 1.88 | 97.5 | Palliative (P) | 2015-07-16 | 2015-07-16 | Mitomycin Intravesical | Y | Y | 280030744 | PACLITAXEL |
| 280006362 | 280003901 | 1.71 | 45.6 | Adjuvant (A) | 2014-08-13 | 2014-08-21 | Capecitabine | 02 | N | 280030755 | CAPECITABINE |
| 280006363 | 280003902 | null | 78.8 | Curative (C) | 2016-12-06 | 2016-12-06 | LANREOTIDE | null | null | 280030761 | CISPLATIN + FLUOROURACIL + RT |
| 280006364 | 280003902 | 1.59 | 49 | Palliative (P) | 2017-11-23 | 2017-11-23 | Bevacizumab + Cape + Oxali 21day | 2 | N | 280030761 | DOXORUBICIN + OLARATUMAB |
| 280006365 | 280003903 | null | null | Curative (C) | 2016-02-26 | 2016-02-26 | PACLITAXEL | N | N | 280030765 | DE-ESCALATE TRIAL |
| 280006366 | 280003904 | 1.58 | 73.9 | Palliative (P) | 2016-11-11 | 2016-12-03 | Doxorubicin + Olaratumab | N | N | 280030767 | DOXORUBICIN + OLARATUMAB |
| 280006367 | 280003904 | null | 80.6 | Curative (C) | 2014-07-03 | 2014-07-10 | Cisplatin + Fluorouracil + RT 5day | N | Y | 280030767 | BEAM |
| 280006368 | 280003905 | 1.72 | 79.3 | Adjuvant (A) | 2016-10-26 | 2016-10-26 | Capecitabine + Cisplatin | N | N | 280030770 | CAV |
| 280006369 | 280003906 | 1.75 | 91 | Curative (C) | 2014-07-08 | 2014-07-11 | DABRAFENIB | 02 | N | 280030772 | IVA |
| 280006370 | 280003906 | null | null | Neo-adjuvant (N) | 2014-01-13 | 2014-08-25 | MITOMYCIN | N | N | 280030772 | COMPARE TRIAL |
| 280006371 | 280010126 | null | 67 | Palliative (P) | 2016-05-06 | 2016-07-16 | Abiraterone | null | N | 280030774 | TRABECTEDIN |
| 280006372 | 280003907 | 1.81 | null | Curative (C) | 2017-01-06 | 2017-01-16 | IVADo | Y | null | 280030775 | EURO-EWING |
| 280006373 | 280003908 | 1.81 | null | Palliative (P) | 2014-12-06 | 2014-12-24 | OCTREOTIDE | 2 | N | 280030778 | DOCETAXEL + GEMCITABINE |
| 280006374 | 280003909 | null | 84.5 | null | null | 2016-08-21 | Capecitabine | null | null | 280030780 | CAPECITABINE + CARBOPLATIN |
| 280006375 | 280008132 | null | 54 | Palliative (P) | 2016-09-03 | 2016-09-30 | Enzalutamide | 02 | N | 280030781 | DOXORUBICIN + OLARATUMAB |
| 280006376 | 280008132 | 1.8 | null | Palliative (P) | null | 2014-01-14 | Capecitabine + Cisplatin | N | N | 280030781 | TRABECTEDIN |
| 280006377 | 280003910 | 1.61 | 67.7 | Palliative (P) | 2016-01-02 | 2016-01-09 | EW EuroEwing 99 : VIDE | 01 | N | 280030785 | IMATINIB |
| 280006378 | 280003910 | 1.61 | null | Curative (C) | 2015-08-27 | 2015-09-18 | LANREOTIDE | N | N | 280030785 | COMPARE TRIAL |
| 280006379 | 280003910 | null | 68 | Palliative (P) | 2014-04-24 | 2014-05-12 | CISPLATIN + ETOPOSIDE | 02 | null | 280030785 | CARBO + FLUOROURACIL |
| 280006380 | 280003911 | 1.74 | 76.9 | Palliative (P) | 2015-08-17 | 2015-08-20 | Capecitabine | N | N | 280030789 | DOXORUBICIN + OLARATUMAB |
| 280006381 | 280003912 | 1.9 | 70 | Curative (C) | 2017-06-27 | 2017-06-27 | Doxorubicin + Olaratumab | 02 | N | 280030790 | IVA |
| 280006382 | 280003913 | null | 28.25 | Adjuvant (A) | 2017-10-27 | 2017-10-27 | Ifosfamide | N | N | 280030791 | CAV |
| 280006383 | 280003913 | 1.65 | null | Palliative (P) | 2013-10-18 | 2013-10-28 | CARBOPLATIN + GEMCITABINE | N | N | 280030791 | IVA |
| 280006384 | 280003913 | 1.71 | 90 | Palliative (P) | 2015-05-22 | 2015-06-21 | OST Euramos 1 Closed Trial - AP | 02 | N | 280030791 | MAP |
| 280006385 | 280003913 | 1.7 | 62.4 | Curative (C) | 2013-12-31 | 2013-12-31 | CARBOPLATIN + CETUXIMAB | N | N | 280030791 | EURO-EWING |
| 280006386 | 280003914 | 0 | null | Palliative (P) | 2015-08-10 | 2015-08-13 | MELPHALAN | N | N | 280030799 | CYCLOPHOSPHAMIDE |
| 280006387 | 280003915 | 1.74 | 105.5 | Palliative (P) | 2014-12-11 | 2014-12-29 | EW EuroEwing 2012 Arm A VIDE | null | N | 280030800 | CARBOPLATIN + CETUXIMAB + FU |
| 280006388 | 280003915 | 1.81 | 112 | Palliative (P) | 2013-01-13 | 2014-02-03 | DABRAFENIB | 2 | N | 280030800 | IVA |
| 280006389 | 280003916 | 1.72 | 68.6 | Not known (9) | 2016-05-23 | 2016-05-29 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 280030802 | CARBO + FLUOROURACIL |
| 280006390 | 280003917 | 0 | 76.5 | Palliative (P) | 2017-09-15 | 2017-09-19 | VIDE | 02 | N | 280030803 | DOCETAXEL + GEMCITABINE |
| 280006391 | 280003918 | 1.65 | null | Curative (C) | 2012-07-23 | 2012-07-23 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280030804 | VINCRISTINE |